Kern M J, Deligonul U, Serota H, Gudipati C, Buckingham T
Cardiology Division, St. Louis University Hospital, MO.
Cathet Cardiovasc Diagn. 1990 Apr;19(4):229-36. doi: 10.1002/ccd.1810190402.
Intracoronary papaverine commonly produces striking QT interval prolongation with rare but serious ventricular dysrhythmias reported. Because of 3 cases of severe papaverine-induced dysrhythmia in our laboratory, QT intervals and hemodynamic and intracoronary velocity data collected during intracoronary papaverine administration were retrospectively reviewed in 34 patients; 20 patients with angiographically normal coronary arteries (group 1) and 14 patients (group 2) before and (group 2) after single-vessel left coronary angioplasty. QT intervals increased from 394 +/- 44 to 464 +/- 73 msec, 414 +/- 47 to 504 +/- 95 msec, and 410 +/- 41 to 486 +/- 75 msec for groups 1 and 2 before and after angioplasty, respectively (all P less than 0.01). There was no correlation with hemodynamic, electrocardiographic, or coronary vasodilatory reserve responses and change in QTc interval. In the 3 index patients having significant papaverine-related arrhythmias, a baseline QT interval was prolonged (after prior papaverine exposure) in only 1 in association with torsade de pointes. These data indicate that QT interval prolongation after papaverine is a common occurrence, but that the production of ventricular dysrhythmia is probably idiosynchratic in origin. In view of these findings, we recommend that appropriate antiarrhythmic preparations be in place for patients receiving intracoronary papaverine.
冠状动脉内注射罂粟碱通常会导致明显的QT间期延长,并伴有罕见但严重的室性心律失常的报道。由于我们实验室有3例严重的罂粟碱诱发的心律失常病例,我们对34例患者在冠状动脉内注射罂粟碱期间收集的QT间期、血流动力学和冠状动脉内速度数据进行了回顾性分析;其中20例冠状动脉造影正常的患者(第1组),以及14例单支左冠状动脉血管成形术前(第2组)和术后(第2组)的患者。第1组和血管成形术前、后的第2组患者的QT间期分别从394±44毫秒增加到464±73毫秒、从414±47毫秒增加到504±95毫秒、从410±41毫秒增加到486±75毫秒(所有P均小于0.01)。QTc间期的变化与血流动力学、心电图或冠状动脉舒张储备反应之间无相关性。在3例有明显的与罂粟碱相关心律失常的指标患者中,仅1例在出现尖端扭转型室速时基线QT间期延长(此前曾接触过罂粟碱)。这些数据表明,罂粟碱注射后QT间期延长很常见,但室性心律失常的发生可能是特发性的。鉴于这些发现,我们建议为接受冠状动脉内注射罂粟碱的患者准备适当的抗心律失常制剂。